METABOLIC & GLP-1

Tirzepatide

High-dose dual GLP-1 / GIP receptor agonist research peptide.

Dose
60 mg / vial
Form
Lyophilized powder
Purity
>99% HPLC-verified
Origin
U.S. synthesis
PRICE $ TBD
Synthesized in U.S.A. HPLC-verified PharmaGrade

ABOUT THIS COMPOUND

Tirzepatide 60 MG.

The 60 mg presentation of Tirzepatide provides double the working volume per vial, intended for higher-throughput research protocols and extended study arms. Same molecule, same chain of custody.

Tirzepatide engages both the GLP-1 and GIP receptors and remains one of the most-studied dual-agonist research compounds in modern endocrinology. HPLC-verified, lyophilized, sealed under inert atmosphere.

SPECIFICATIONS

Molecule. Method. Documentation.

Compound Data

Molecular weight
~4,814 Da
Sequence length
39 amino acids
Form
Lyophilized powder
Purity (HPLC)
>99%
Solubility
Reconstitute with bacteriostatic water for research
Storage
Long-term at -20°C; sealed, dark, dry

Storage & Handling

Storage temperature
-20°C long-term
Shelf life (sealed)
24 months
Reconstituted shelf life
30 days at 2–8°C
Reconstitution
Bacteriostatic water (research use)
Documentation
Lot-specific COA on request

RESEARCH APPLICATIONS

What researchers study.

All applications are investigative. This compound is sold for research-use only and is not for human or animal consumption.

  • Dual GLP-1 / GIP receptor research
  • Long-duration research protocols
  • Comparative-agonism investigation

QUALITY ASSURANCE

Every vial, the same standard.

U.S. Made Molecule built on American soil
>99% HPLC-verified purity
Lot-Tested COA available on request
PharmaGrade Pharmaceutical-grade synthesis

A current-lot Certificate of Analysis is available for every compound. Email us with the product and lot number; we'll send the documentation. Read about our lab testing →

YOU MAY ALSO RESEARCH

Related compounds.

QUESTIONS?

Talk to a human.

Lot questions, COA requests, institutional accounts, reach the team directly.

CONTACT US